Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent L-lysine-containing domains
Author
dc.contributor.author
Gonzàlez Gronow, Mario
Author
dc.contributor.author
Fiedler Temer, Jenny
Author
dc.contributor.author
Farías Gómez, Cristian
Author
dc.contributor.author
Wang, Fang
Author
dc.contributor.author
Ray, Rupa
Author
dc.contributor.author
Ferrell, Paul D.
Author
dc.contributor.author
Pizzo, Salvatore V.
Admission date
dc.date.accessioned
2018-06-21T14:33:25Z
Available date
dc.date.available
2018-06-21T14:33:25Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Biochemical and Biophysical Research Communications 490 (2017) 855-860
es_ES
Identifier
dc.identifier.other
http://dx.doi.org/10.1016/j.bbrc.2017.06.131
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/149113
Abstract
dc.description.abstract
Myelin basic protein (MBP) is a key component of myelin, the specialized lipid membrane that encases
the axons of all neurons. Both plasminogen (Pg) and tissue-type plasminogen activator (t-PA) bind to
MBP with high affinity. We investigated the kinetics and mechanisms involved in this process using
immobilized MBP and found that Pg activation by t-PA is significantly stimulated by MBP. This mechanism
involves the binding of t-PA via a lysine-dependent mechanism to the Lys91 residue of the MBP
NH2-terminal region Asp82 -Pro99, and the binding of Pg via a lysine-dependent mechanism to the Lys122
residue of the MBP COOH-terminal region Leu109-Gly126. In this context, MBP mimics fibrin and because
MBP is a plasmin substrate, our results suggest direct participation of the Pg activation system on MBP
physiology.
es_ES
Patrocinador
dc.description.sponsorship
Fondo Nacional de
Desarrollo Cientίfico y Tecnolόgico de Chile, FONDECYT No 1130451
Figueroa-Reyes, Tatiana; Sáez, David M.; Mansilla, Eloy L.; Sánchez, Rodrigo V.; Nogales Gaete, Jorge; Delgado, Iris B.(2011)
Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile ...
Depix, María S.; Martínez, Jorge; Santibañez, Francisco; Rovirosa, Juana; San Martín Barrientos, Aurelio; Maccioni Baraona, Ricardo(1998)
We investigated the effects of the drug 14-keto-stypodiol diacetate (SDA) extracted from the seaweed product Stypopodium flabelliforme, in inhibiting the cell growth and tumor invasive behavior of DU-145 human prostate ...